LifeVantage Corporation

LifeVantage Corporation

LFVNยทNASDAQ

$8.32

-0.18%
Consumer DefensivePackaged Foods

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes. It also provides anti-aging skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, the company offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website, as well as through a network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and China. LifeVantage Corporation is headquartered in Lehi, Utah.

At a Glance

Live Snapshot
Market Cap$104.96M
EPS0.8000
P/E Ratio10.40
Earnings Date08/25/2026
3Y+2.0%
5Y+22.0%
10Y+43.0%
3Y-5.0%
5Y+46.0%
10Y-2.0%
3Y+10.0%
5Y+4.0%
10Y+186.0%
lfvn

LifeVantage Corporation Funding & Solvency Profile

LFVN ยท NASDAQ
Cash & Cash Equivalents20.20M
Net Receivables3.93M
Inventory20.67M
Other Current Assets6.09M
Total Current Assets51 M
Property, Plant & Equipment14.25M
Goodwill & Intangible Assets245.00K
Long-Term Investments0.00
Other Non-Current Assets601.00K
Total Non-Current Assets15 M
Total Assets
71.96M

Financial Health Analysis

Current Ratio

1.87x

Strong liquidity. The company has adequate resources to meet short-term liabilities.

Debt-to-Equity Ratio

1.08x

Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.

Working Capital

24 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

71% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

LifeVantage Corporation Balance Sheet

LFVN โ€ข NASDAQ

LifeVantage Corporation Balance SheetJun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017Jun 2016Jun 2015Jun 2014Jun 2013Jun 2012Jun 2011Jun 2010Jun 2009Jun 2008Jun 2007Jun 2006
ASSETS
CURRENT ASSETS
20.2M
16.9M
21.6M
20.2M
23.2M
22.1M
18.8M
16.7M
11.5M
7.9M
13.9M
20.4M
26.3M
24.6M
6.4M
1.6M
608.8K
196.9K
160.8K
228.1K
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
350K
340K
520K
1.1M
0.0
3M
20.2M
16.9M
21.6M
20.2M
23.2M
22.1M
18.8M
16.7M
11.5M
7.9M
13.9M
20.4M
26.3M
24.6M
6.7M
2M
1.1M
1.3M
160.8K
3.2M
3.9M
3.3M
1.9M
5.1M
4M
2.6M
3.3M
2.5M
2.2M
1.6M
3.2M
6M
3.9M
333.3K
941.8K
401.6K
767.9K
98K
398.5K
260.6K
3.3M
2.9M
1.6M
3.3M
2.9M
2.6M
2.1M
2.1M
1.3M
1.6M
1M
1.3M
1.8M
333.3K
941.8K
401.6K
648.1K
98K
398.5K
107.9K
635K
313K
241K
1.8M
1M
0.0
0.0
451K
913K
0.0
2.2M
4.7M
2.2M
0.0
0.0
0.0
119.8K
0.0
0.0
0.0
20.7M
15.1M
16.1M
16.5M
16.1M
13.9M
13.8M
13.6M
16.6M
25.1M
9.2M
8.8M
10.5M
11.4M
2.1M
493.9K
740K
104.4K
27.8K
45K
0.0
0.0
0.0
5.2M
4.8M
5.2M
7.3M
6.1M
5.3M
6.3M
3M
4.6M
2.3M
1.3M
487.8K
153.9K
82.7K
196.1K
178K
316.7K
6.1M
2.4M
4.8M
0.0
0.0
5.2M
0.0
0.0
0.0
2.3M
1.1M
158K
2.9M
2.5M
487.8K
0.0
6.5K
278K
388.8K
555.3K
50.9M
37.6M
44.3M
47M
48.1M
43.9M
43.2M
38.9M
35.5M
42.4M
30.5M
40M
45.9M
38.8M
10.3M
3M
3M
2M
1.2M
4.4M
NON-CURRENT ASSETS
14.2M
17.4M
17.8M
20.5M
24.8M
8.1M
7.1M
6.6M
3.1M
3.5M
5.8M
6.9M
5.7M
2M
227.8K
196.4K
274.7K
63.6K
108.9K
245K
245K
323K
455K
587K
719K
851K
983K
1.1M
1.2M
1.7M
1.9M
2M
1.7M
1.9M
2M
2M
2.2M
2.3M
2.3M
5.5M
245K
323K
455K
587K
719K
851K
983K
1.1M
1.2M
1.7M
1.9M
2M
1.7M
1.9M
2M
2M
2.2M
2.3M
2.3M
5.5M
0.0
0.0
0.0
0.0
2.2M
2.2M
0.0
0.0
0.0
0.0
1.1M
1.4M
0.0
0.0
0.0
113.6K
130K
0.0
0.0
0.0
6M
4.3M
3M
1.3M
1.2M
2.2M
2.7M
3.3M
4.1M
1.1M
235K
1.3M
730K
1.5M
0.0
0.0
0.0
0.0
0.0
0.0
601K
680K
569K
1.3M
1.7M
1.7M
1.3M
1.2M
1.2M
1.5M
1.4M
2.4M
1.4M
342.1K
32.2K
844.8K
149.8K
241.9K
340.4K
316.6K
21.1M
22.7M
21.8M
23.7M
30.7M
15M
12.1M
12.2M
9.7M
7.9M
10.4M
14M
9.5M
5.7M
2.2M
3.2M
2.7M
2.6M
2.8M
6M
72M
60.3M
66.1M
70.7M
78.7M
58.9M
55.3M
51.1M
45.2M
50.3M
40.9M
54M
55.5M
44.5M
12.5M
6.2M
5.7M
4.5M
3.9M
10.4M
LIABILITIES
CURRENT LIABILITIES
14.5M
15.3M
12.6M
17.4M
18.5M
4.3M
16M
3.9M
5.1M
22.1M
10.9M
13.3M
14M
10.5M
2.8M
1.4M
2.2M
139.8K
148.7K
613.8K
5.1M
6.3M
4.2M
7.9M
7.6M
3.5M
5.2M
3.8M
4.9M
8.9M
2.6M
2.9M
5.2M
3.6M
799.2K
770.9K
2M
139.8K
148.7K
613.8K
9.4M
9M
8.4M
9.5M
10.9M
784K
10.8M
39K
215K
13.3M
8.3M
10.4M
8.9M
6.9M
2M
591K
121.6K
0.0
0.0
0.0
4.8M
2.7M
1.5M
4.7M
2.7M
1.8M
6.7M
5.3M
2.4M
2.2M
7.5M
2.4M
4.2M
3.9M
2.2M
809.5K
631.8K
338.3K
230.8K
401.3K
0.0
0.0
0.0
0.0
0.0
1.2M
1.5M
2M
2M
2M
11.1M
4.7M
0.0
0.0
434K
1.1M
581.4K
167.5K
2.3K
0.0
1.9M
1.8M
1.5M
2.6M
2.2M
1.2M
-10.2M
0.0
0.0
-10M
-8.3M
-10.4M
0.0
0.0
0.0
0.0
41.5K
0.0
0.0
0.0
2.2M
2.5M
1.7M
2.2M
2.8M
784K
592K
39K
215K
1.2M
809K
1.9M
742K
545.7K
0.0
0.0
0.0
0.0
0.0
0.0
711K
860K
834K
78K
319K
792K
998K
1.1M
1.7M
2.4M
990K
887K
545K
153.6K
33.9K
34.8K
822K
510.8K
818.3K
1.1M
5.3M
1.6M
3.1M
971K
1.5M
15.7M
1.1M
11.5M
12.2M
1.9M
-4.7M
1.5M
2M
1.2M
7.9M
1.8M
328.5K
0.0
0.0
0.0
27.2M
22.3M
19.6M
25.7M
25.2M
25M
26.2M
23.8M
23.4M
28.6M
25.9M
22.7M
20.6M
16M
13.4M
5.1M
3.7M
1.2M
1.2M
2.2M
NON-CURRENT LIABILITIES
0.0
0.0
0.0
0.0
0.0
0.0
0.0
3.4M
5.4M
7.4M
9.6M
25.1M
0.0
0.0
0.0
121K
382.2K
223.5K
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-1.1M
-235K
-1.3M
0.0
216.9K
21K
0.0
23.7K
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.1M
235K
1.3M
730K
1.5M
0.0
0.0
0.0
0.0
0.0
0.0
289K
198K
299K
308K
694K
604K
1.9M
2M
1.9M
2.2M
2.1M
2.2M
243K
0.0
19.9M
17.2M
8.5M
0.0
0.0
0.0
10.1M
12M
11.9M
13.5M
16.7M
604K
1.9M
5.4M
7.4M
9.6M
11.7M
27.3M
973K
216.9K
19.9M
17.3M
8.8M
223.5K
846.0
3.1K
11.7M
13.6M
13.1M
15.8M
18.2M
1.2M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
41.5K
846M
846.0
3.1K
37.3M
34.3M
31.5M
39.2M
41.9M
25.6M
28.1M
29.2M
30.7M
38.1M
37.6M
50M
21.5M
16.2M
33.3M
22.4M
12.6M
1.4M
1.2M
2.2M
SHAREHOLDERS' EQUITY
1K
1K
1K
1K
1K
1K
1K
1K
14K
14K
98K
102K
121K
110.9K
98.8K
61.5K
54K
24.8K
22.3K
22.1K
140M
136.6M
134.3M
131.1M
129M
126.4M
127.1M
124.7M
121.6M
119.2M
117.6M
115.2M
110.4M
105.2M
67.6M
21.5M
17M
17.9M
15.4M
14M
-104.1M
-108.7M
-98.3M
-98.4M
-92.3M
-93.3M
-100M
-102.7M
-107M
-108.1M
-114.1M
-111.2M
-76.5M
-77M
-88.5M
-37.7M
-23.9M
-14.8M
-12.7M
-9M
-1.2M
-1.9M
-1.4M
-1.1M
104K
144K
62K
14K
-94K
43K
-251K
-116K
-113K
-21.2K
-59.7K
-31.8K
-165.3K
-156.9K
-99.7K
-55.6K
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
165.3K
0.0
0.0
0.0
34.6M
26M
34.6M
31.5M
36.8M
33.3M
27.2M
21.9M
14.5M
12.1M
3.3M
4M
33.9M
28.3M
-20.8M
-16.2M
-6.9M
3.2M
2.7M
8.3M
34.6M
26M
34.6M
31.5M
36.8M
33.3M
27.2M
21.9M
14.5M
12.1M
3.3M
4M
33.9M
28.3M
-20.8M
-16.2M
-6.9M
3.2M
2.7M
8.3M
SUMMARY
72M
60.3M
66.1M
70.7M
78.7M
58.9M
55.3M
51.1M
45.2M
50.3M
40.9M
54M
55.5M
44.5M
12.5M
6.2M
5.7M
4.5M
3.9M
10.4M
0.0
0.0
0.0
0.0
2.2M
2.2M
0.0
0.0
0.0
0.0
1.1M
1.4M
0.0
0.0
350K
453.6K
650K
1.1M
0.0
3M
11.7M
13.6M
13.1M
15.8M
18.2M
1.2M
1.5M
5.4M
7.4M
9.4M
20.8M
29.8M
0.0
0.0
434K
1.3M
1M
391K
3.1K
3.1K
-8.5M
-3.3M
-8.5M
-4.4M
-5M
-21M
-17.4M
-11.2M
-4M
1.5M
6.9M
9.4M
-26.3M
-24.6M
-5.9M
-380.3K
396.3K
194.1K
-157.6K
-225K
12,689,070
12,689,070
12,689,070
12,689,070
12,689,070
12,689,070
12,689,070
12,689,070
12,689,070
12,689,070
12,689,070
12,689,070
12,689,070
12,689,070
12,689,070
12,689,070
12,689,070
12,689,070
12,689,070
12,689,070

SEC Filings

LFVN - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
8-K

8-K 2026

N/A

May 06, 2026
May 06, 2026
2026
10-Q

10-Q 2026 Q1

Q1

May 06, 2026
March 31, 2026
2026
8-K

8-K 2026

N/A

April 16, 2026
April 13, 2026
2026
S-3

S-3

N/A

March 10, 2026
March 10, 2026
ย 
8-K

8-K 2026

N/A

February 04, 2026
January 30, 2026
2026
10-Q

10-Q 2025 Q4

Q4

February 04, 2026
December 31, 2025
2025
8-K

8-K 2025

N/A

December 09, 2025
December 03, 2025
2025
8-K

8-K 2025

N/A

November 12, 2025
November 06, 2025
2025
10-Q

10-Q 2025 Q3

Q3

November 04, 2025
September 30, 2025
2025
8-K

8-K 2025

N/A

November 04, 2025
November 04, 2025
2025
Showing 1 to 10 of 396 filings